Hanna Nowicka
Overview
Explore the profile of Hanna Nowicka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
202
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mackowiak B, Ostrowska K, Kulcenty K, Kazmierska J, Ostapowicz J, Nowicka H, et al.
Rep Pract Oncol Radiother
. 2024 Aug;
29(2):148-154.
PMID: 39143964
Background: Head and neck squamous carcinoma (HNSC) is the sixth most common neoplasm, with a 40-50% overall survival rate. HNSC standard treatment depends on tumor size, metastasis or human papillomavirus...
2.
Wesoly J, Pstrag N, Derylo K, Michalec-Wawiorka B, Derebecka N, Nowicka H, et al.
Am J Cancer Res
. 2024 Jun;
14(5):2665.
PMID: 38859867
[This corrects the article on p. 1863 in vol. 13, PMID: 37293153.].
3.
Nowicka H, Sekrecka A, Blaszczyk K, Kluzek K, Chang C, Wesoly J, et al.
Int J Mol Sci
. 2023 Dec;
24(24).
PMID: 38139463
In addition to the canonical ISGF3 and non-canonical STAT2/IRF9 complexes, evidence is emerging of the role of their unphosphorylated counterparts in IFN-dependent and -independent ISG transcription. To better understand the...
4.
Wesoly J, Pstrag N, Derylo K, Michalec-Wawiorka B, Derebecka N, Nowicka H, et al.
Am J Cancer Res
. 2023 Jun;
13(5):1863-1883.
PMID: 37293153
Due to their involvement in the development of various cancers Transmembrane Proteins (TMEMs) are the focus of many recent studies. Previously we reported TMEM de-regulation in clear cell Renal Cell...
5.
Boroujeni M, Sekrecka A, Antonczyk A, Hassani S, Sekrecki M, Nowicka H, et al.
Front Immunol
. 2022 Jun;
13:888897.
PMID: 35663932
A disease outbreak in December 2019, caused by a novel coronavirus SARS-CoV-2, was named COVID-19. SARS-CoV-2 infects cells from the upper and lower respiratory tract system and is transmitted by...
6.
Blaszczyk K, Nowicka H, Kostyrko K, Antonczyk A, Wesoly J, Bluyssen H
Cytokine Growth Factor Rev
. 2016 Apr;
29:71-81.
PMID: 27053489
In the canonical pathway of IFN-I-mediated signaling, phosphorylation of STAT1 and STAT2 leads to heterodimerization and interaction with IRF9. This complex, also known as IFN-stimulated gene factor 3 (ISGF3), then...
7.
Blaszczyk K, Olejnik A, Nowicka H, Ozgyin L, Chen Y, Chmielewski S, et al.
Biochem J
. 2015 Jan;
466(3):511-24.
PMID: 25564224
Evidence is accumulating for the existence of a signal transducer and activator of transcription 2 (STAT2)/interferon regulatory factor 9 (IRF9)-dependent, STAT1-independent interferon alpha (IFNα) signalling pathway. However, no detailed insight...
8.
Chmielewski S, Olejnik A, Sikorski K, Pelisek J, Blaszczyk K, Aoqui C, et al.
PLoS One
. 2014 Dec;
9(12):e113318.
PMID: 25478796
Signal integration between IFNγ and TLRs in immune cells has been associated with the host defense against pathogens and injury, with a predominant role of STAT1. We hypothesize that STAT1-dependent...
9.
Kontek R, Nowicka H
Drug Chem Toxicol
. 2012 Nov;
36(3):335-42.
PMID: 23126525
Drug-target interactions can be modified by adding modulatory agents to increase treatment efficacy and clinical outcome. Combination chemotherapy has become increasingly important because drugs acting synergistically can achieve therapeutic effects...